Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.62 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.62 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.62 |
| ▸ | HTT | P42858 | 1/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
| ▸ | CTSK | P43235 | 6/20 | 0.48 |
| ▸ | CTSS | P25774 | 4/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA7 | P43166 | 1/20 | 0.44 |
| ▸ | CTSL | P07711 | 1/20 | 0.42 |
| ▸ | CTSB | P07858 | 1/20 | 0.42 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8211606 | 1.00 | CYP1A2 (0.62) | CYP1A2CYP2C9CYP2C19HTTSMN1; SMN2 | |
| SCHEMBL12942567 | 0.88 | CYP1A2 (0.51) | CYP1A2CYP2C9CYP2C19HTTSMN1; SMN2 | |
| SCHEMBL12071191 | 0.88 | CYP1A2 (0.64) | CYP1A2CYP2C9CYP2C19HTTSMN1; SMN2 | |
| SCHEMBL12070120 | 0.88 | CYP1A2 (0.64) | CYP1A2CYP2C9CYP2C19HTTSMN1; SMN2 | |
| SCHEMBL12069015 | 0.88 | CYP1A2 (0.64) | CYP1A2CYP2C9CYP2C19HTTSMN1; SMN2 | |
| SCHEMBL11173165 | 0.87 | CYP1A2 (0.48) | CYP1A2CYP2C9CYP2C19HTTSMN1; SMN2 | |
| SCHEMBL2531297 | 0.87 | CYP1A2 (0.48) | CYP1A2CYP2C9CYP2C19HTTSMN1; SMN2 | |
| SCHEMBL1846647 | 0.87 | CYP1A2 (0.48) | CYP1A2CYP2C9CYP2C19HTTSMN1; SMN2 | |
| SCHEMBL7308713 | 0.87 | CYP1A2 (0.59) | CYP1A2CYP2C9CYP2C19HTTSMN1; SMN2 | |
| SCHEMBL31758034 | 0.86 | CYP1A2 (0.56) | CYP1A2CYP2C9CYP2C19HTTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120004764-A | Preparation method of amino acid tert-butyl ether | 四川什邡市三高生化实业有限公司 | 2025-05-16 | — | — | CN | claimed |
| US-20250270184-A1 | PROCESSES FOR THE PREPARATION OF FINERENONE | ASSIA CHEMICAL INDUSTRIES LTD. (IL) | 2025-08-28 | — | — | US | disclosed |
| CN-120004764-A | Preparation method of amino acid tert-butyl ether | 四川什邡市三高生化实业有限公司 | 2025-05-16 | — | — | CN | disclosed |
| CN-119775170-A | Preparation method of sabatier starter intermediate | 浙江工业大学 | 2025-04-08 | — | — | CN | disclosed |
| EP-4511365-A1 | PROCESSES FOR THE PREPARATION OF FINERENONE | Teva Pharmaceuticals International GmbH (CH) | 2025-02-26 | — | — | EP | disclosed |
| EP-4425181-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | Bertis Inc (KR) | 2024-09-04 | — | — | EP | disclosed |
| US-20240011979-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTES | BERTIS INC. (KR) | 2024-01-11 | — | — | US | disclosed |
| WO-2023205164-A1 | PROCESSES FOR THE PREPARATION OF FINERENONE | TEVA PHARMACEUTICALS INTERNATIONAL GMBH (CH) | 2023-10-26 | — | — | WO | disclosed |
| US-20230190943-A1 | ALGINIC ACID DERIVATIVE BONDED TO NONSTEROIDAL ANTI-INFLAMMATORY COMPOUND | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2023-06-22 | — | — | US | disclosed |
| US-20230168196-A1 | METHOD FOR DETECTING TYROSINE RESIDUE IN SAMPLE, AND TERBIUM COMPOUND TO BE USED FOR SUCH DETECTION | NEC CORPORATION (JP) | 2023-06-01 | — | — | US | disclosed |
| EP-1106606-A2 | N-(3-piperidinylcarbonyl)-beta-alanine derivatives as paf antagonists | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-06-13 | — | — | EP | disclosed |
| US-6211175-B1 | P-AMINOMETHYLBENZOIC ACID DERIVATIVES; CARDIOVASCULAR DISORDERS; NONHYPOTENSIVE | KUREHA CHEMICAL INDUSTRY CO., LTD. (JP) | 2001-04-03 | — | — | US | disclosed |
| EP-0807628-B1 | Aromatic compound and pharmaceutical composition | KUREHA CHEMICAL IND CO LTD (JP) | 2000-12-20 | — | — | EP | disclosed |
| US-5932575-A | Cardiac diseases improving agents | KUREHA CHEMICAL INDUSTRY CO., LTD. (JP) | 1999-08-03 | — | — | US | disclosed |
| US-5863913-A | ALLEVIATION OF RENAL DYSFUNCTION WITHOUT AFFECTING BLOOD PRESSURE AT A LOW BLOOD CONCENTRATION. | KUREHA CHEMICAL INDUSTRY CO., LTD. (JP) | 1999-01-26 | — | — | US | disclosed |
| EP-0864568-A1 | Agents for treatment of cardiac diseases | KUREHA CHEMICAL INDUSTRY CO., LTD. (JP) | 1998-09-16 | — | — | EP | disclosed |
| EP-0807628-A1 | Aromatic compound and pharmaceutical composition | Kureha Chemical Industry Co., Ltd. (JP) | 1997-11-19 | — | — | EP | disclosed |
| EP-0669912-A1 | N-(3-PIPERIDINYLCARBONYL)-BETA-ALANINE DERIVATIVES AS PAF ANTAGONISTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1995-09-06 | — | — | EP | disclosed |
| WO-1995008536-A1 | N-(3-PIPERIDINYLCARBONYL)-BETA-ALANINE DERIVATIVES AS PAF ANTAGONISTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1995-03-30 | — | — | WO | disclosed |
| EP-0292923-A2 | Piperidine compounds and pharmaceutical uses thereof | Yoshitomi Pharmaceutical Industries, Ltd. (JP) | 1988-11-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250270184-A1 | PROCESSES FOR THE PREPARATION OF FINERENONE | CYP11B1, CYP11B2, HSD17B7 | CYP1A2 88/4885CYP2C9 397/4885CYP2C19 159/4885 |
| US-20230190943-A1 | ALGINIC ACID DERIVATIVE BONDED TO NONSTEROIDAL ANTI-INFLAMMATORY COMPOUND | ALG1, ALG8, ALG3 | CYP1A2 4495/4885CYP2C9 3313/4885CYP2C19 3352/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.